Daniel J. Indelicato, M.D. and and Carmen Allegra, M.D. have been honored by the National Cancer Institute, or NCI, for their achievements as members of the National Clinical Trial Network Adolescent and Young Adult Working Group to develop and implement clinical trials for adolescent and young adult…
The Royal College of Radiologists (RCR) has awarded Daniel J. Indelicato, MD, Professor and Associate Vice Chair of the University of Florida Department of Radiation Oncology, its prestigious Honorary Fellowship. Dr. Indelicato accepted the Fellowship diploma in person at the Royal College, London, on March 24, 2023.
Daniel Indelicato, MD, Professor, Mendenhall Endowed Chair, and Associate Vice Chair of the UF Department of Radiation Oncology, has been awarded a one-year, $160,000 NIH/NCIÂ grant for the United States Pediatric Proton Therapy study. This is a prospective cohort study including pediatric cancer patients treated with proton therapy and a…
The Department of Radiation Oncology has announced that three outstanding faculty members have been named as 2018-19 UF College of Medicine University Term Professors. Dr. Brad Hoppe, UF Health Proton Therapy Institute Radiation Oncologist and Associate Professor, James E. Lockwood, Jr., Endowed Chair of Proton Therapy, Department of Radiation Oncology…
Several faculty and residents from the Department of Radiation Oncology were published in the International Journal of Radiation Oncology, Biology, and Physics’s special issue on particle therapy. We are excited to have the following first authors contribute to the topic: Julie A. Bradley, MD, “Initial Report of a…
NATIONALLY RANKED
Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.
DEFINING OPTIMAL TREATMENTS
The seminar has three concurrent programs for radiation therapy, oncology nursing, and radiation oncology.
EXPLORE THE
Our Mission is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the people we serve.
